European Journal of Clinical Pharmacology

Papers
(The H4-Index of European Journal of Clinical Pharmacology is 19. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
Therapeutic drug monitoring of oral targeted antineoplastic drugs125
Global prevalence and types of complementary and alternative medicines use amongst adults with diabetes: systematic review and meta-analysis52
Proton pump inhibitor use: systematic review of global trends and practices42
A phase I study assessing the safety, tolerability, immunogenicity, and low-density lipoprotein cholesterol-lowering activity of immunotherapeutics targeting PCSK937
Ivy leaf (Hedera helix) for acute upper respiratory tract infections: an updated systematic review31
Pharmacotherapy of Alzheimer’s disease: an overview of systematic reviews30
Predisposing factors for the development of diabetic ketoacidosis with lower than anticipated glucose levels in type 2 diabetes patients on SGLT2-inhibitors: a review30
Safety and efficacy of tolcapone in Parkinson’s disease: systematic review29
A real or apparent decrease in glomerular filtration rate in patients using olaparib?26
Essentials in saline pharmacology for nasal or respiratory hygiene in times of COVID-1925
Prevalence, contributory factors and severity of medication errors associated with direct-acting oral anticoagulants in adult patients: a systematic review and meta-analysis23
Selective serotonin reuptake inhibitors in the treatment of depression, anxiety, and post-traumatic stress disorder in substance use disorders: a Bayesian meta-analysis22
Use of ketamine in patients with refractory severe asthma exacerbations: systematic review of prospective studies21
The effect of tocilizumab on mortality in hospitalized patients with COVID-19: a meta-analysis of randomized controlled trials21
Improving medication adherence and effective prescribing through a patient-centered prescription model in patients with multimorbidity20
Trends in the use of oral anticoagulants, antiplatelets and statins in four European countries: a population-based study20
Use of ketamine and esketamine for depression: an overview of systematic reviews with meta-analyses19
Medication-related adverse events in health care—what have we learned? A narrative overview of the current knowledge19
Effect of SAcubitril/Valsartan on left vEntricular ejection fraction and on the potential indication for Implantable Cardioverter Defibrillator in primary prevention: the SAVE-ICD study19
Second-generation antipsychotic use during pregnancy and risk of congenital malformations19
0.35160493850708